N-Terminal domain antiandrogen
N-Terminal domain antiandrogen is a type of antiandrogen that works by inhibiting the androgen receptor's N-terminal domain. This is a unique mechanism of action compared to other antiandrogens, which typically work by blocking the receptor's ligand-binding domain.
Mechanism of Action[edit | edit source]
N-Terminal domain antiandrogens inhibit the androgen receptor by binding to its N-terminal domain. This prevents the receptor from being activated by androgens, such as testosterone and dihydrotestosterone. As a result, these drugs can reduce the effects of androgens in the body.
Uses[edit | edit source]
N-Terminal domain antiandrogens are used in the treatment of conditions that are caused or worsened by androgens. This includes prostate cancer, which is often driven by androgens.
Examples[edit | edit source]
One example of an N-Terminal domain antiandrogen is EPI-001. This drug is still in the experimental stages and has not yet been approved for use in humans.
See Also[edit | edit source]
References[edit | edit source]
N-Terminal domain antiandrogen Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD